171 related articles for article (PubMed ID: 8222482)
1. Single-dose pharmacokinetics of cefpirome in patients receiving hemodialysis and in patients treated by continuous ambulatory peritoneal dialysis.
Veys N; Lameire N; Malerczyk V; Lehr KH; Rosenkranz B; Ringoir S
Clin Pharmacol Ther; 1993 Oct; 54(4):395-401. PubMed ID: 8222482
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics of cefpirome in long-term hemodialysis with high-flux membranes.
Thalhammer F; Schmaldienst S; Elmenyawi I; Atteneder M; Burgmann H; Hollenstein U; Georgopoulos A; Graninger W; Putz D; Rosenkranz AR; Mayer G; Hörl WH; Breyer S
Clin Pharmacol Ther; 1996 Dec; 60(6):645-50. PubMed ID: 8988066
[TBL] [Abstract][Full Text] [Related]
3. Intraperitoneal administration of acyclovir in patients receiving continuous ambulatory peritoneal dialysis.
Burgess ED; Gill MJ
J Clin Pharmacol; 1990 Nov; 30(11):997-1000. PubMed ID: 2243158
[TBL] [Abstract][Full Text] [Related]
4. Effect of hemodialysis and peritoneal dialysis on aztreonam pharmacokinetics.
Gerig JS; Bolton ND; Swabb EA; Scheld WM; Bolton WK
Kidney Int; 1984 Sep; 26(3):308-18. PubMed ID: 6542606
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cidofovir in renal insufficiency and in continuous ambulatory peritoneal dialysis or high-flux hemodialysis.
Brody SR; Humphreys MH; Gambertoglio JG; Schoenfeld P; Cundy KC; Aweeka FT
Clin Pharmacol Ther; 1999 Jan; 65(1):21-8. PubMed ID: 9951427
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.
Manley HJ; Bailie GR; Asher RD; Eisele G; Frye RF
Perit Dial Int; 1999; 19(1):65-70. PubMed ID: 10201343
[TBL] [Abstract][Full Text] [Related]
7. Disposition of didanosine in HIV-seropositive patients with normal renal function or chronic renal failure: influence of hemodialysis and continuous ambulatory peritoneal dialysis.
Knupp CA; Hak LJ; Coakley DF; Falk RJ; Wagner BE; Raasch RH; van der Horst CM; Kaul S; Barbhaiya RH; Dukes GE
Clin Pharmacol Ther; 1996 Nov; 60(5):535-42. PubMed ID: 8941026
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of flecainide in a patient undergoing continuous ambulatory peritoneal dialysis.
Bailie GR; Waldek S
J Clin Pharm Ther; 1988 Apr; 13(2):121-4. PubMed ID: 3134365
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of aztreonam administered i.p. in continuous ambulatory peritoneal dialysis (CAPD) patients.
Nikolaidis P; Dombros N; Alexiou P; Balaskas E; Tourkantonis A
Perit Dial Int; 1989; 9(1):57-9. PubMed ID: 2488183
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of cefdinir and its transfer to dialysate in patients with chronic renal failure undergoing continuous ambulatory peritoneal dialysis.
Tomino Y; Fukui M; Hamada C; Inoue S; Osada S
Arzneimittelforschung; 1998 Aug; 48(8):862-7. PubMed ID: 9748717
[TBL] [Abstract][Full Text] [Related]
11. Disposition and bioavailability of ceftazidime after intraperitoneal administration in patients receiving continuous ambulatory peritoneal dialysis.
Stea S; Bachelor T; Cooper M; de Souza P; Koenig K; Bolton WK
J Am Soc Nephrol; 1996 Nov; 7(11):2399-402. PubMed ID: 8959631
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal production of erythropoietin with continuous ambulatory peritoneal dialysis.
Chandra M; Clemons G; Sahdev I; McVicar M; Bluestone P
Pediatr Nephrol; 1993 Jun; 7(3):281-3. PubMed ID: 8518099
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of ornidazole in patients with renal insufficiency; influence of haemodialysis and peritoneal dialysis.
Merdjan H; Baumelou A; Diquet B; Chick O; Singlas E
Br J Clin Pharmacol; 1985 Feb; 19(2):211-7. PubMed ID: 3986079
[TBL] [Abstract][Full Text] [Related]
16. Moxalactam epimer disposition in patients undergoing continuous ambulatory peritoneal dialysis.
Morse G; Janicke D; Cafarell R; Piontek K; Apicella M; Jusko WJ; Walshe J
Clin Pharmacol Ther; 1985 Aug; 38(2):150-6. PubMed ID: 4017417
[TBL] [Abstract][Full Text] [Related]
17. Steady-state pharmacokinetics of lamivudine in human immunodeficiency virus-infected patients with end-stage renal disease receiving chronic dialysis.
Bohjanen PR; Johnson MD; Szczech LA; Wray DW; Petros WP; Miller CR; Hicks CB
Antimicrob Agents Chemother; 2002 Aug; 46(8):2387-92. PubMed ID: 12121909
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of teicoplanin in patients undergoing continuous ambulatory peritoneal dialysis.
Stamatiadis D; Papaioannou MG; Giamarellos-Bourboulis EJ; Marinaki S; Giamarellou H; Stathakis CP
Perit Dial Int; 2003; 23(2):127-31. PubMed ID: 12713078
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic modeling of bidirectional transfer during peritoneal dialysis.
Janicke DM; Morse GD; Apicella MA; Jusko WJ; Walshe JJ
Clin Pharmacol Ther; 1986 Aug; 40(2):209-18. PubMed ID: 3731683
[TBL] [Abstract][Full Text] [Related]
20. Acyclovir pharmacokinetics in a patient on continuous ambulatory peritoneal dialysis.
Shah GM; Winer RL; Krasny HC
Am J Kidney Dis; 1986 Jun; 7(6):507-10. PubMed ID: 3717158
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
